MARIA ANTONIA SAORNIL ALVAREZ-rekin lankidetzan egindako argitalpenak (7)

2018

  1. Episcleral brachytherapy as an effective alternative in vasoproliferative tumors

    International Journal of Ophthalmology, Vol. 11, Núm. 12, pp. 2017-2020

  2. Radiobiological doses, tumor, and treatment features influence on local control, enucleation rates, and survival after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: Part I

    Journal of Contemporary Brachytherapy, Vol. 10, Núm. 4, pp. 337-346

  3. Radiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: Part II

    Journal of Contemporary Brachytherapy, Vol. 10, Núm. 4, pp. 347-359

  4. Visual outcome after posterior uveal melanoma episcleral brachytherapy including radiobiological doses

    Journal of Contemporary Brachytherapy, Vol. 10, Núm. 2, pp. 123-131

2017

  1. Pattern of Local Recurrence After I-125 Episcleral Brachytherapy for Uveal Melanoma in a Spanish Referral Ocular Oncology Unit

    American Journal of Ophthalmology, Vol. 180, pp. 39-45

2012

  1. Prevalence of ocular and oculodermal melanocytosis in Spanish population with uveal melanoma

    Eye, Vol. 26, Núm. 1, pp. 159-162

2001

  1. Use of general brachytherapy planning system with epiescleral plaques

    Physica Medica